“I wish more people understood how hard ILD is even if we don’t look sick,” shares Amanda H. (dx with scleroderma in 2015). “It’s hard being so short of breath...
Read More
“Being diagnosed with interstitial lung disease has completely reshaped my life—physically, emotionally, and mentally,” Paul shares. "It’s frustrating, sometimes heartbreaking, to feel your body no longer cooperate the way it...
Read More
“Hope isn’t just a feeling—it’s a choice I make every morning," Kristina H. says (dx 2022). "Even when my body feels weak, my spirit is unbreakable." For years, she felt...
Read More
The CONQUEST clinical trial reaches a major milestone: 125+ sites in 24 countries 🌍 We are excited to announce that CONQUEST, the global platform clinical trial created by the SRF,...
Read More
We want to hear from you! Take our new communications survey and let us know how we can make our outreach more useful, meaningful, and relevant to you. But don’t...
Read More
Living with scleroderma? Learn about its impact on the lungs at our upcoming webinar. 🫁 Join us for a special ILD Day webinar in recognition of Interstitial Lung Disease (ILD)...
Read More
HEADER: CONQUEST team connects with global scleroderma research leaders at IWS 2025 🌍 Last month, members of the CONQUEST team attended the International Workshop for Scleroderma Research (IWS), held July...
Read More
Watch now: How Dr. Michael Longaker, Stanford University and SRF-Funded researcher, brings a unique perspective to solving scleroderma. Right now, you have a powerful opportunity to accelerate critical scleroderma research....
Read More
